Insulin resistance and cardiovascular complications in patients with essential hypertension

American Journal of Hypertension

Volumn 9, Issue 12 I, 1996, Pages 1165-1171

  Kamide, Kei ^a   Nagano, Masahiro ^a   Nakano, Nobuaki ^a   Yo, Yoshikage ^a   Kobayashi, Ryuichi ^a   Rakugi, Hiromi ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

carotid wall thickness; essential hypertension; insulin resistance; left ventricular hypertrophy; vascular endothelial function

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR FUNCTION; CAROTID ARTERY; CLINICAL ARTICLE; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HEART HYPERTROPHY; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; RISK FACTOR;

BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBSERVER VARIATION; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; VASODILATION;

EID: 0030446155     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00263-4     Document Type: Article

References (28)

1. Assmann G, Schulte H: The Prospective Cardiovascular Münster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary artery disease. Am Heart J 1988; 116:1713-1724.
2. Kannel WB: Risk factors in hypertension. J Cardiovasc Pharmacol 1989; 13(suppl 1):4-10.
3. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
4. Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989; 149:1514-1520.
5. Rowe JW: Effect of insulin and glucose infusion on sympathetic nervous system activity in normotensive man. Diabetes 1981;30:219-225.
6. Stout RW, Bierman EL, Ross R: Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975;36:319-327.
7. Sowers JR, Standley PR, Ram JL, et al: Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. 1993;6:260S-270S.
8. Lind L, Andersson P, Andren B, et al: Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13:433-438.
9. DeFronzo RJ, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
10. Joint National Committee: The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1993; 153:154-183.
11. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977;55:613-618.
12. Iiyama K, Nagano M, Nagano N, et al: Effect of age on hypertension-induced wall thickening of the carotid artery assessed using ultrasonography. Cardiol Elderly 1995;3:37-42.
13. Pignoli P, Tremoli E, Poli A, et al: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-1406.
14. Salonen R, Salonen JT: Carotid athelosclerosis in relation to systolic and diastolic blood pressure: Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Med 1991;23:23-27.
15. Celermajer DS, Sorensen KE, Gooch VM, et al: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
16. Rizza RA: Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981;240:E630-E639.
17. Bergman RN: Assessment of insulin sensitivity in vivo: a critical review. Diabetes Metab Rev 1989;5:411-429.
18. Messerli FH: Clinical determinants and consequences of left ventricular hypertrophy. Am J Med 1983;26:51-56.
19. Sasson Z, Rasooly Y, Bhesania T, et al: Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation 1993;88(pt 1):1431-1436.
20. Hill DJ, Milner RDG. Insulin as a growth factor. Pediatr Res 1985; 19:879-886.
21. Donohue TJ, Dworkin LD, Lango MN, et al: Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation 1994; 89:799-809.
22. Delafontaine P, Lou H, Alexander RW: Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells. Hypertension 1991; 18:742-747.
23. Dengel DR, Pratley RE, Hagberg JM, et al: Impaired insulin sensitivity and maximal responsiveness in older hypertensive men. Hypertension 1994;23:320-324.
24. Broughton DL, James OW, Alberti KG, et al: Peripheral and hepatic insulin sensitivity in healthy elderly human subjects. Eur J Clin Invest 1991;21:13-21.
25. Uehata A, Gerhard MD, Meredith IT, et al: Close relationship of endothelial dysfunction in coronary and brachial artery (abst). Circulation 1993;88(pt 2):I-618.
26. Iiyama K, Nagano M, Nagano N, et al: Impaired endothelium-dependent vasodilation in patients with essential hypertension. Am Heart J (in press).
27. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al: Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994;24:471-476.
28. Salonen JT: Ultrasonography assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-1249.